Physician

Francis Roosevelt Gilliam, MD

According to 2025 Medicare claims, Francis Gilliam, MD (NPI: 1891704474) practices cardiac electrophysiology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PRISMA HEALTH MEDICAL GROUP-MIDLANDS (NPI: 1003307166; TIN: 471345819) and primary practice location at 29150-4975. Gilliam is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Gilliam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,926 traditional Medicare patients, billed 6,010 HCPCS/CPT codes, and received $252,594 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,151 prescription claims across 566 beneficiaries totaling $1,391,619 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 48 claims. Open Payments data shows 86 records totaling $1,905. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $131,030 to $252,594. Similarly, Part D prescription costs have moved sharply higher in recent years, from $29,574 to $1,391,619. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	990	2,145	$131,030
2016	1,130	2,188	$113,204
2017	1,136	3,185	$160,412
2018	950	2,600	$137,397
2019	1,164	3,331	$173,517
2020	1,359	4,485	$202,052
2021	1,113	3,321	$138,649
2022	1,496	5,418	$225,952
2023	1,463	5,196	$239,747
2024	1,926	6,010	$252,594

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	191	$29,574
2016	63	243	$32,644
2017	156	1,040	$87,863
2018	207	1,783	$211,199
2019	329	2,140	$399,840
2020	452	3,743	$739,536
2021	433	2,805	$558,757
2022	415	2,884	$675,999
2023	499	3,576	$1,026,480
2024	566	4,151	$1,391,619

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	48	$5,049
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	377	390	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	587	1,099	$91
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	131	397	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	462	593	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,247	1,856	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	411	24,954	$466,376
Vyndamax	Tafamidis	13	390	$291,781
Entresto	Sacubitril/Valsartan	221	12,257	$265,766
Xarelto	Rivaroxaban	125	6,330	$114,072
Farxiga	Dapagliflozin Propanediol	54	3,284	$61,051

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$1,905	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Francis Roosevelt Gilliam, MD?

Tedicare shows public-source Medicare data for Francis Roosevelt Gilliam, MD (NPI 1891704474), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Francis Roosevelt Gilliam, MD have ACO affiliation data?

Francis Roosevelt Gilliam, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Francis Roosevelt Gilliam, MD?

Francis Roosevelt Gilliam, MD is linked to PRISMA HEALTH MEDICAL GROUP-MIDLANDS (billing NPI 1003307166) in the available physician profile data.

Does Francis Roosevelt Gilliam, MD have Open Payments data?

Francis Roosevelt Gilliam, MD has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.